-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HoFELNGCnjsPLD+xq+Cc8Ikdr6R0xqFICnRKfLe8BZsmwwhxpoitmf02eacbyAQF Gh1j4l8/rFmdB+ZwDgP8+g== 0001181431-05-010121.txt : 20050215 0001181431-05-010121.hdr.sgml : 20050215 20050215163457 ACCESSION NUMBER: 0001181431-05-010121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050128 FILED AS OF DATE: 20050215 DATE AS OF CHANGE: 20050215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER FELIX CENTRAL INDEX KEY: 0001087940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21699 FILM NUMBER: 05617578 BUSINESS ADDRESS: STREET 1: TISCH FAMILY INTERESTS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125212420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER JULIAN CENTRAL INDEX KEY: 0001087939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21699 FILM NUMBER: 05617579 BUSINESS ADDRESS: STREET 1: TISCH FAMILY INTERESTS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125212420 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VIROPHARMA INC CENTRAL INDEX KEY: 0000946840 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232789550 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 397 EAGLEVIEW BLVD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6104587300 MAIL ADDRESS: STREET 1: 397 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baker Biotech Capital III (Z) (GP), LLC CENTRAL INDEX KEY: 0001307728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21699 FILM NUMBER: 05617580 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 212 521 2418 MAIL ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10021 4 1 rrd68529.xml FORM 4 X0202 4 2005-01-28 0 0000946840 VIROPHARMA INC VPHM 0001307728 Baker Biotech Capital III (Z) (GP), LLC 667 MADISON AVENUE NEW YORK NY 10021 0 0 1 0 0001087939 BAKER JULIAN 667 MADISON AVENUE NEW YORK NY 10021 0 0 1 0 0001087940 BAKER FELIX 667 MADISON AVENUE NEW YORK NY 10021 0 0 1 0 Common Stock 2005-01-31 4 P 0 451 3.0194 A 451 I See Footnote 6.0% Convertible Senior Secured Notes due 2009 2.50 2005-01-28 4 P 0 31000 A 2009-10-18 Common Stock 12400 120000 I See Footnote 6.0% Convertible Senior Secured Notes due 2009 2.50 2005-01-31 4 P 0 67000 A 2009-10-18 Common Stock 26800 187000 I See Footnote 6.0% Convertible Senior Secured Notes due 2009 2.50 2005-01-31 4 P 0 22000 A 2009-10-18 Common Stock 8800 209000 I See Footnote In addition to Baker Biotech Capital III (Z) (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Biotech Capital III (Z) (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were members of a group with such security holders. However, the Reporting Persons disclaim that they and any other person or persons in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein. Represents shares and/or notes owned directly by Baker Biotech Fund III (Z), L.P., a limited partnership of which the sole general partner is Baker Biotech Capital III (Z), L.P., a limited partnership of which the sole general partner is Baker Biotech Capital III (Z) (GP), LLC. Felix J. Baker and Julian C. Baker are the controlling members of Baker Biotech Capital III (Z) (GP), LLC. Immediately. 140% of the principal amount. 142% of the principal amount. 142.25% of the principal amount. /s/ Julian C. Baker, as Managing Member of Baker Biotech Capital III (Z) (GP), LLC 2005-02-14 /s/ Julian C. Baker 2005-02-14 /s/ Felix J. Baker 2005-02-14 -----END PRIVACY-ENHANCED MESSAGE-----